about
Calcium and vitamin D supplementation during androgen deprivation therapy for prostate cancer: a critical reviewPotential implications of adjuvant endocrine therapy for the oral health of postmenopausal women with breast cancerSkeletal response to resistance and impact training in prostate cancer survivors.Timing of androgen deprivation therapy use and fracture risk among elderly men with prostate cancer in the United States.Fracture risk in women with breast cancer: a population-based study.Chronic Diseases among Older Cancer Survivors.Cathepsin L targeting in cancer treatment.Arterial to end-tidal carbon dioxide pressure gradient increases with age in the steep Trendelenburg position with pneumoperitoneum.Long-term Toxicity of Cancer Treatment in Older PatientsBreast cancer survivorship symptom management: current perspective and future development.Management of osteoporosis among the elderly with other chronic medical conditionsBone marrow mesenchymal stem cells participate in prostate carcinogenesis and promote growth of prostate cancer by cell fusion in vivo.Antiresorptive therapy in the management of cancer treatment-induced bone loss.Age-related Disparity: Breast Cancer in the Elderly.Osteoporosis and prostate cancer: a cross-sectional study of Danish men with prostate cancer before androgen deprivation therapy.Awareness, concern, and communication between physicians and patients on bone health in cancer.Osteoporosis knowledge, health beliefs, and healthy bone behaviours in patients on androgen-deprivation therapy (ADT) for prostate cancer.American Cancer Society prostate cancer survivorship care guidelines.Online Educational Tool to Promote Bone Health in Cancer Survivors.Assessing information needs on bone health in cancer survivors.
P2860
Q24597422-A33B87B7-6629-4D6F-AC63-6520856867E7Q26863685-3840688A-2207-406A-8F9C-1B55FD786DA3Q33911381-E4451CA1-7CD0-45AA-A975-EA14CCFEC90FQ35855513-F1060954-AC59-49BA-8188-04B49D42BF7EQ35991921-8013D6E1-0190-4569-B919-1A5B6FF167E2Q36204488-747E9285-E227-4115-BA71-E091E79BC962Q36218199-ECA3A12B-C3A8-4D39-BDB9-D3688D56EB7EQ36285266-4F5A7B6F-8232-4F62-83EA-81B230FD19F3Q36821673-10FC7410-8682-4492-BBE0-B97B42AF88DFQ36956837-5BF61C83-05E0-488C-9487-4DE11E7BFC54Q37156112-72F53CF0-3426-4D79-B77D-31F7933D3516Q37327627-076DEF19-FA80-414F-BBE6-A7BF8F532653Q38313112-13332F3D-D692-4D03-A649-AD1BA7A8C4DAQ38997213-2E4DB9E0-F1FD-40D5-9F67-2940329987CFQ43720651-596A0E03-32BB-4D20-8CB9-852928C5DC51Q45012423-4225C9CA-C585-411B-85C1-154464EAE027Q47921412-E39F981E-A55F-484A-AC93-3F87E1E8B568Q48073617-5D849470-7B26-4DAE-9876-22C419D94BEFQ48330464-3BCC2A3D-5007-4AEF-8475-D45C041AC259Q50553402-45D7081F-0CD4-44EB-876C-859878D4E3A3
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 04 May 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Aging and osteoporosis in breast and prostate cancer.
@en
Aging and osteoporosis in breast and prostate cancer.
@nl
type
label
Aging and osteoporosis in breast and prostate cancer.
@en
Aging and osteoporosis in breast and prostate cancer.
@nl
prefLabel
Aging and osteoporosis in breast and prostate cancer.
@en
Aging and osteoporosis in breast and prostate cancer.
@nl
P2860
P356
P1433
P1476
Aging and osteoporosis in breast and prostate cancer.
@en
P2093
Ari VanderWalde
Arti Hurria
P2860
P304
P356
10.3322/CAAC.20103
P407
P577
2011-05-04T00:00:00Z